About Piramal Imaging
A division of Piramal Enterprises, Ltd., Piramal Imaging was formed in 2012 with the acquisition of the molecular imaging research and development portfolio of Bayer Pharma AG. Because of the acquisition, many key leaders joined the company, and we gained access to a pipeline of PET imaging agents
- Focus : Manufacturer
- Employees: 201-500
- Industry : Pharma
Product portfolio of Piramal Imaging
Here you will find Piramal Imaging GmbH
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
